Background/aims-In 1998 the PPPZR1B gene encoding the A subunit of the seri
ne/ threonine protein phosphatase was identified as a putative tumour suppr
essor gene in lung and colon cancer in the chromosome region 11q22-24. The
aim of the present study was to determine the type of alterations in primar
y rectal cancers as well as colon cancers and the correlation between these
alterations and clinicopathological data.
Methods-Mutation analyses of the PPP2R1B gene sequence encoding the binding
sites of the catalytic C subunit (Huntington elongation A subunit TOR (HEA
T) repeats 11-15) and partial binding sites of the regulatory B subunit wer
e carried out on cDNA samples from 30 primary colorectal cancer specimens a
nd corresponding normal tissues using a combination of the polymerase chain
reaction and subsequent direct DNA sequencing.
Results-Five missense mutations producing amino acid substitutions were det
ected in the four colon cancer cases (13.3%; four of 30 colorectal cancers)
: (15)glycine (GGT) to alanine (GCT) and (499)leucine (TTA) to isoleucine (
ATA) in the same case, and (498)valine (GTG) to glutamic acid (GAG), (500)v
aline (GTA) to glycine (GGA), and (365)serine (TCT) to proline (CCT). Of th
ese five mutations, three (60%) were located in HEAT repeat 13 and four (80
%) showed T to other nucleotide substitutions. In addition, a normal polymo
rphism, (478)leucine, was found. No correlation was found between these mut
ations and clinicopathological data.
Conclusion-Our results suggest that the PPP2R1B gene is one of the true tar
gets at 11q23, and its inactivation is involved in the development of all t
ypes of colorectal cancers.